At this threshold, studies of breast cancer using GWAS have missed the association of BRCA1 and BRCA2 (prevalences <<1%), even though they are associated with a lifetime risk of breast cancer in women of 65% and 45%, respectively [43, 44]. The gene discussed is BRCA2; the disease is breast carcinoma.